NCT04864639 (TOC) is a NA clinical trial of Transition of Care Model in Diabetes Mellitus, sponsored by Duke University.

Who is sponsoring NCT04864639?

NCT04864639 is sponsored by Duke University.

What drugs are being tested in NCT04864639?

Interventions in NCT04864639: Transition of Care Model.

What condition does NCT04864639 study?

NCT04864639 studies Diabetes Mellitus.

Is NCT04864639 still recruiting?

NCT04864639 is currently completed. Last updated 17 March 2023.

Are results published for NCT04864639?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-03-17 · How we verify

NCT04864639: TOC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Transition of Care Model From Hospital to Community for Hispanic/Latino Adult Patients With Diabetes.

Completed NA Results posted Last updated 17 March 2023

What this trial tests

NA trial testing Transition of Care Model in Diabetes Mellitus in 12 participants. Completed in 17 February 2022.

Timeline

4 August 2021

Primary endpoint
17 February 2022

17 February 2022

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	12
Start date	4 August 2021
Primary completion	17 February 2022
Estimated completion	17 February 2022
Sites	1 location across United States

Drugs / interventions tested

Transition of Care Model

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Duke University

Who can join

18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Emergency Department (ED) Visits Within 30 Days Post Discharge Primary · 30 days post-discharge

The number of times the participant has revisited the ED after their discharge from the hospital.

Group	Value	95% CI
Transition of Care	0	± 0

Unplanned Readmissions to the Hospital Within 30 Days Post Discharge Secondary · up to 30 days

The number of times the patient is readmitted to the hospital for unplanned admissions after discharge.

Group	Value	95% CI
Transition of Care	0	± 0

Sponsor's own description

This pilot study was designed to address the existing gap in the transition of care of Hispanic/Latino Adults with diabetes from hospital to community. The over arching goal of this study is to develop, test, and determine the feasibility of a transition of care (ToC) model from the hospital to the community for adult Hispanic/Latino patients with diabetes.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A transition of care model from hospital to community for Hispanic/Latino adult patients with diabetes: design and rationale for a pilot study.
Corsino L, Padilla BI. · · 2022 · cited 2× · PMID 36471392 · DOI 10.1186/s40814-022-01203-z
A Transition of Care Model from Hospital to Community for Hispanic/Latino Adult Patients with Diabetes: Design and Rationale for a Pilot Study
Corsino L, Padilla BI. · · 2022 · cited 1× · DOI 10.21203/rs.3.rs-1355870/v1
A pilot study testing a new transition of care model from hospital to the community for Hispanic/Latino adults with diabetes to reduce emergency department visits and hospital re-admissions.
Esteve LMA, Padilla BI, Pichardo-Lowden A, Granados I, et al · · 2024 · PMID 39342332 · DOI 10.1186/s40814-024-01534-z

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04864639 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 17 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04864639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing